Identification and functional annotation of genome-wide ER-regulated genes in breast cancer based on ChIP-Seq data

From MaRDI portal
(Redirected from Publication:1929586)





Summary: Estrogen receptor (ER) is a crucial molecule symbol of breast cancer. Molecular interactions between ER complexes and DNA regulate the expression of genes responsible for cancer cell phenotypes. However, the positions and mechanisms of the ER binding with downstream gene targets are far from being fully understood. ChIP-Seq is an important assay for the genome-wide study of protein-DNA interactions. In this paper, we explored the genome-wide chromatin localization of ER-DNA binding regions by analyzing ChIP-Seq data from MCF-7 breast cancer cell lines. By integrating three peak detection algorithms and two data sets, we localized 933 ER binding sites, 92\% among which were located far away from promoters, suggesting long-range control by ER. Moreover, 489 genes in the vicinity of ER binding sites were identified as estrogen response elements by comparison with expression data. In addition, 836 single nucleotide polymorphisms (SNPs) in or near 157 ER-regulated genes were found in the vicinity of ER binding sites. Furthermore, we annotated the function of the nearest-neighbor genes of these binding sites using Gene Ontology (GO), KEGG, and GeneGo pathway data bases. The results revealed novel ER-regulated genes pathways for further experimental validation. ER was found to affect every developed stage of breast cancer by regulating genes related to the development, progression, and metastasis. This study provides a deeper understanding of the regulatory mechanisms of ER and its associated genes.





Describes a project that uses

Uses Software






This page was built for publication: Identification and functional annotation of genome-wide ER-regulated genes in breast cancer based on ChIP-Seq data

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1929586)